The triglyceride-glucose index as an adiposity marker and a predictor of fat loss induced by a low-calorie diet

Publikation: Bidrag til tidsskriftTidsskriftartikelfagfællebedømt

  • Fernando Vidal-Ostos
  • Omar Ramos-Lopez
  • Ellen E Blaak
  • Arne Astrup
  • J Alfredo Martinez

Background: This study aimed to investigate the putative role of the Triglyceride-glucose index (TyG index) computed as ln[TG (mg/dL) × glucose (mg/dL)/2] and derived proxies as predictors of adiposity and weight loss changes after a low calorie diet (LCD) intervention.

Methods: A total of 744 adult participants from the multicenter DIOGenes intervention study were prescribed a LCD (800 kcal/day) during 8 weeks. Body composition and fat content at baseline and after 8 weeks were estimated by DEXA/BIA. A multivariate analysis approach was used to estimate the difference in ∆Weight1-2 (kg), ∆BMI1-2 (kg/m2) or ∆Fat1-2 (%) between the basal value (point 1) and after 8 weeks following a LCD (point 2), respectively. The TyG index at baseline (TyG1), after following the LCD for 8 weeks (TyG2), or the TyG index differences between both time points (∆TyG1-2) were analyzed as predictors of weight and fat changes.

Results: TyG1 was associated with ∆Weight1-2 (kg) and ∆BMI1-2 (kg/m2), with β=0.812 (p = 0.017) and β=0.265 (p = 0.018), respectively. Also, TyG2 values were inversely related to ∆Fat1-2 (%), β=-1.473 (p = 0.015). Moreover, ∆TyG1-2 was associated with ∆Weight1-2 (kg) and ∆Fat1-2 (%), β= 0.689 (p = 0.045) and β=1.764 (p = 0.002), respectively. Furthermore, an association between TyG2 and resistance to fat loss was found (= 0.015).

Conclusion: TyG1 index is a good predictor of weight loss induced by LCD. Moreover, TyG2 was closely related to resistance to fat loss, while ∆TyG1-2 values were positively associated with body fat changes. Therefore, TyG index and derived estimations could be used as markers of individualized responses to energy restriction and a surrogate of body composition outcomes in clinical/epidemiological settings in obesity conditions.

OriginalsprogEngelsk
Artikelnummere13674
TidsskriftEuropean Journal of Clinical Investigation
Vol/bind52
Udgave nummer1
Antal sider12
ISSN0960-135X
DOI
StatusUdgivet - 2022

Bibliografisk note

CURIS 2022 NEXS 012
This article is protected by copyright. All rights reserved.

Antal downloads er baseret på statistik fra Google Scholar og www.ku.dk


Ingen data tilgængelig

ID: 278037258